Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / BIOTECHNOLOGY
-
Total 13F shares
-
909,559
-
Share change
-
+43,321
-
Total reported value
-
$70,309,819
-
Price per share
-
$77.33
-
Number of holders
-
93
-
Value change
-
+$3,371,337
-
Number of buys
-
25
-
Number of sells
-
25
Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q2 2021
As of 30 Jun 2021,
INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
909,559 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, ROYAL BANK OF CANADA, OSAIC HOLDINGS, INC., BANK OF AMERICA CORP /DE/, LPL Financial LLC, PFG Advisors, UBS Group AG, Anfield Capital Management, LLC, and People's United Financial, Inc..
This page lists
93
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.